Skip to Main Content

Advertisement

Skip Nav Destination

Optimizing CAR T-Cell Therapy in Relapsed/Refractory ALL

December 30, 2021
On location

Noelle V. Frey, MD, discusses the challenges of balancing the promises of chimeric antigen receptor T-cell therapy with its side effects in patients with relapsed/refractory acute lymphocytic leukemia.

Advertisement

Connect with us:

CURRENT ISSUE
August 2022

Advertisement

Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement

X